Francis G. Giles

Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older With Previously Untreated Acute Myeloid Leukemia

Francis G. Giles, David A. Rizzieri, Judith E. Karp et al. · Journal of Clinical Oncology · 2006 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +14

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

Yesid Alvarado, Apostolia M. Tsimberidou, Hagop M. Kantarjian et al. · Cancer Chemotherapy and Pharmacology · 2003 · 71 citations

Medicine, Oncology, Pharmacology +14

Phase 1 Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Concomitant Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine (HDAra-C) Consolidation in Newly Diagnosed Patients with AML.

Francis G. Giles, Charles A. Schiffer, Hagop M. Kantarjian et al. · Blood · 2004 · 71 citations

Medicine, Oncology, Pharmacology +13

Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma

Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo et al. · Molecular Cancer Therapeutics · 2011 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17